Exhibit 99.1
Third Quarter 2013 Earnings Release
October 22, 2013
IDEX PROPRIETARY & CONFIDENTIAL
IDEX PROPRIETARY & CONFIDENTIAL
2
Agenda
IDEX Outlook
Q3 Financial Performance
Q3 Segment Performance
Fluid & Metering
Health & Science
Fire & Safety / Diversified
Guidance Update
Q&A
IDEX PROPRIETARY & CONFIDENTIAL
IDEX PROPRIETARY & CONFIDENTIAL
3
Replay Information
Dial toll–free: 855.859.2056
International: 404.537.3406
Conference ID: #26074681
Log on to: www.idexcorp.com
IDEX PROPRIETARY & CONFIDENTIAL
4
Cautionary Statement Under the Private Securities Litigation Reform Act
This presentation and discussion will include forward- looking statements.
Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those differences, including those presented in our most recent annual report and other company filings with the SEC.
IDEX PROPRIETARY & CONFIDENTIAL
5
IDEX Q3 Financial Performance
R EPS*
$ 0 $480 $491
Revenue
$1.00 $0.66 $0.78
Organic: 1% growth 18% growth
$250 $400 550 Q3
20 2 20 3 $0.00 $0.50 Q3
2012 2013 2012 2013
150 bps expansion
23% growth
Operating Margin* Free Cash Flow
14% 16% 18% 20% 18.3% 19.8% $50 $75 $100 $125 $92 $113 Q3 2012 2013 Q3 2012 2013
* Q3 2012 EPS / Operating Margin data adjusted for restructuring expenses ($7.1M)
IDEX PROPRIETARY & CONFIDENTIAL
Outstanding EPS, Margin & FCF performance
6
Fluid & Metering
Orders Revenue O i M i *
Organic: 9% growth Organic: 6% growth 300 bps expansion
Operating Margin*
$100 $200 $300 $198 $212 15% 20% 25% 21.4% 24.4% $100 $200 $300 $198 $217 Q3 Organic 6%
Q3 Summary:
$0 Q3 2012 2013 10% Q3 2012 2013 $0 Q3 2012 2013
Revenue Mix: Acquisition 0%
Fx 1%
?? Strong organic order and revenue growth driven by increases across all FMT platforms
?? Operating margin improved 300 bps on volume strength and the continued benefit of cost-out actions and disciplined management Total 7%
?? Energy benefited from continued strength in North American electronic retrofits and aviation
?? Municipal water services showing strong orders and project funnel
* Q3 2012 Operating Margin data adjusted for restructuring expense
IDEX PROPRIETARY & CONFIDENTIAL
Organic orders up 9 percent, organic sales up 6 percent
7
Health & Science
Orders Revenue O i M i *
$176 $179
Organic: 2% decline 330 bps expansion
$166 $174
Organic: 2% growth
Operating Margin*
$100 $200 10% 15% 20% 25% 17.3% 20.6% $100 $200 $0 Q3 2012 2013 Q3 2012 2013 $0 Q3 2012 2013
Q3 Revenue Mix: Organic -2% Q3 Summary:
Acquisition 4%
Fx -1%
?? Operating margins expanded 330 basis points on the strength of focused cost-out initiatives
?? Scientific Fluidics has order and sales growth in every quarter this year
?? Optics & expecting order increase prior to year-end Total 1% Photonics
?? Specialty Seals delivered outstanding growth from their position in the scientific and oil & gas markets
* Q3 2012 Operating Margin data adjusted for restructuring expense
IDEX PROPRIETARY & CONFIDENTIAL
Q3 operating margin of 20.6 percent up 330 bps
8
Fire & Safety/Diversified
Orders Revenue O i M i *
24.8% 21 9%
Organic: 7% decline 290 bps decline
$ 141
Organic: 39% growth
Operating Margin*
$50 $100 $150 $108 $101 10% 15% 20% 25% 21.9% $50 $100 $150 $101 $0 Q3 2012 2013 Q3 2012 2013 $0 Q3 2012 2013
Q3 Revenue Mix: Organic -7% Q3 Summary:
Acquisition 0%
Fx 1%
?? Strong organic order growth from FSG and Dispensing
?? Orders up 39 percent organically, excluding large Dispensing order, still
up 16 percent
?? Another power production facility trailer order at FSG Total -6%
?? FSG has exceptional profitability improvements after facility consolidation
?? Strength at Band-It from North American vehicle platforms orders
* Q3 2012 Operating Margin data adjusted for restructuring expense
IDEX PROPRIETARY & CONFIDENTIAL
Large Dispensing and FSG orders fuel excellent organic growth
9
Outlook: 2013 Guidance Summary
Q4 2013
EPS estimate range: $0.78 – $0.80
Organic revenue growth ~ 5%
Positive revenue impact from acquisition of ~ 1%
Operating margin ~ 19.5%
FY 2013
EPS estimate range: $3.05 – $3.07
– Organic revenue growth ~ 2%
– Positive revenue impact from acquisition of ~ 2%
– Operating margin ~ 19.5%
– Fximpact is immaterial
Other modeling items
– Tax rate ~ 28.5%
– Cap Ex ~ $33 - $36M
– Free Cash Flow will be 145 – 150% of net income
– Continued share repurchases
– EPS estimate excludes future acquisitions and associated costs and charges
IDEX PROPRIETARY & CONFIDENTIAL
IDEX PROPRIETARY & CONFIDENTIAL
Q&A
IDEX PROPRIETARY & CONFIDENTIAL
